The murine mortalin genes, mot-1 and mot-2, are members of the hsp70 family of proteins and dier from each other by only two amino acid residues. Mot-1 is expressed in normal cells and has pancytosolic cellular distribution whereas mot-2 is found in the perinuclear region of immortal cells. We report here that a high level of expression of mot-2 protein resulted in malignant transformation of cells as analysed by anchorage independent growth and nude mice assays. A high level of protein expression is attributed to the 900 bp 3' untranslated region of the cDNA which does not have any transforming activity per se. Mortalin cDNA clones isolated from human transformed cells were also found to have transforming activity in similar assays and a high level of expression was apparent in some of the human immortalized cells that showed non-pancytosolic mortalin immuno¯uorescence. Taken together, the data suggest that nonpancytosolic mortalin may have a role in tumorigenesis.
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Keywords: NIH3T3; malignant transformation; mot-2 protein Cellular immortalization is widely accepted as a key event in the development of cancer. An orderly control of cell proliferation which endows normal somatic cells with a limited proliferation potential (mortal phenotype) is subverted by the loss of tumor suppressor function or activation of oncogene function. While human cells rarely, if ever, become spontaneously immortalized in culture (Bryan and Reddel, 1994; Goldstein, 1990; Hay¯ick and Moorhead, 1961) , murine and other rodent cells do so at a relatively high frequency (Meek et al., 1977) . Many genes have been implicated in these processes (Derventzi et al., 1996; Holt et al., 1996; Smith and Pereira-Smith, 1996; Wadhwa et al., 1991 Wadhwa et al., , 1995 , but the molecular basis for the entry of cells into the senescent or immortal state is still essentially unknown.
We initially cloned two mortalin cDNAs, mot-1 and mot-2, coding for members of the hsp70 family of proteins, that have pancytosolic distribution in normal cells and perinuclear distribution in immortal murine cells, respectively (Wadhwa et al., 1993a,b) . The open reading frames of the two types of murine mortalins dier by two nucleotides, encode proteins diering in two amino acids, and have been shown to arise from distinct genes (Wadhwa et al., 1993a (Wadhwa et al., ,b, 1996 . We have earlier shown an antiproliferative function of pancytosolic mortalin by microinjection of an anti-mortalin antibody into senescent mouse ®broblasts and transfection of mot-1 cDNA into NIH3T3 cells (Wadhwa et al., 1993a,b) . RNA in situ hybridizations and immunohistochemical studies on mortalin in normal murine tissues showed a higher level of expression in nondividing cell populations than in dividing cells. Subsequently, brain tumor tissues were seen to have a high intensity of mortalin staining and in brain tumorderived cell lines the mortalin staining was shown to be nonpancytosolic Takano et al., 1997) .
In the present study, we transfected NIH3T3 cells with a mot-2.1 expression plasmid. Mot-2.1 is a mortalin cDNA clone isolated from RS-4 cells that has a 3' untranslated region (3'UTR) that is 900 bp longer than that of the mot-2 cDNA isolated from NIH3T3 cells (Figure 1a) . Stably transfected cells showed transformed morphology (Table 1 ) and anchorage independent growth (colony forming eciency of 27%) (Figure 1b) . When two such clones were injected into nude mice they formed tumors, whereas the control untransfected and vector transfected clones did not (Table 2) . Hematoxylin-eosin stained tumor sections showed ®brosarcomatous morphology and a perinuclear distribution was apparent by staining with anti-mortalin antibody (Figure 1c ). Only one mot-2 transfected NIH3T3 clone from three experiments showed a similar transformation. NIH3T3 cells transfected with an empty vector (control) did not exhibit such a phenotype in any of the eighteen clones isolated from three independent experiments (Table 1) . These results were consistent with the untransformed phenotype of NIH3T3 cells as reported in other studies Rittling and Denhart, 1992; Tokumitsu et al., 1994) . Protein levels of the tumor suppressor p53 and Oncogene (1998) 17, 907 ± 911 Figure 1 Mot-2.1 cDNA cloning and biological activity. A random primed cDNA library was prepared from RS-4, a spontaneously immortalized clone from the CD1-ICR mouse, in the lZAPII vector. It was screened with a cDNA probe (1.6-kb EcoRI fragment of mot-1 cDNA; Wadhwa et al., 1993a) using standard protocols (Sambrook et al., 1989) . Full sequence of a 3.0 kb isolate, mot-2.1, derived by sequencing with primers from mot-1 sequence (Wadhwa et al., 1993a) and by combining the sequences of its nested deletion derivatives (pBSSK) sequenced by T7 primer is shown (A). cDNA isolates were cloned into the pSRa expression vector containing the hybrid SV40-human immunode®ciency virus promoter/enhancer and the neo R gene and transfected into NIH3T3 cells using Lipofectamine TM (Gibco). Transfectants were selected in 1 mg/ml G418-supplemented growth medium (Dulbecco's modi®ed Eagle's medium supplemented with 10% FBS). About 20 clones were isolated from each transfection using cloning rings and were subsequently maintained in 500 mg/ml G418-supplemented growth medium. Daily observations on morphology and division rate were continued for about 4 ± 6 weeks. Cell morphology of NIH3T3 (a) and one of its mot-2.1 transfected derivatives (b) is shown in (B). For soft agar assays, 1610 2 cells were suspended in 4 ml of 0.3% low melting agarose (Boehringer Mannheim) in DMEM supplemented with 10% FBS and were plated onto a solidi®ed base layer of 0.8% Agar-DMEM in a 60 mm dish. Plates were incubated at 378C in humidi®ed atmosphere and scored for colony formation (B, c-d) by microscopic examination at 1 week intervals for 4 weeks. For nude mice assays, 5610 6 cells suspended in 0.5 ml of growth medium were injected subcutaneously into the right¯ank of nude mice (one site per mouse). Injection sites were monitored for tumor development two to three times per week. Formalin-®xed and paran-embedded 5 mm tumor sections (C) were stained with hematoxylin-eosin for histological analysis of tissue morphology (a) and immunostained using a polyclonal anti-mortalin antibody (b). The 3'UTR of mortalin was ampli®ed by PCR using mot-2.1 clone as template and sense (5'-GTCGACTAATCGTGGCAGTGCATT-3') and antisense (5'-GTCGACCGACCCAGTACTTTTATT-3') primers containing SalI sites for cloning. The ampli®ed product (1 kb) was ®rst cloned in pGEM-T vector (Promega) and sequenced to exclude PCR-generated mutations. The 3'UTR insert was then excised and cloned in the pSRa vector at the SalI site for transfections. the proliferation marker p81/Ezrin in the mot-2.1 transfected clones that showed a transformed phenotype were determined by Western analysis. The expression level of p53 suggested wild type conformation of p53 (Figure 2 ) which was con®rmed by RT ± PCR sequence analyses in control and NIH3T3/mot-2.1 cells. p81/Ezrin was also expressed at equivalent levels in control and NIH3T3/mot-2.1 cells and this was much lower than in RS-4 cells. These analyses con®rmed that the transformed phenotype of NIH3T3/ mot-2.1 clones is likely to be the result of mot-2 overexpression rather than independent events such as p53 mutations or high expression of p81/Ezrin that have been reported to contribute to cellular transformation and tumor progression . Also, RT ± PCR analysis of vascular endothelial growth factor 115 (VEGF 115), a recently identi®ed form of murine VEGF which is highly expressed in stage II immortalized cells , revealed that it is expressed at equivalent levels in control and mot-2.1 transfected NIH3T3 cells (data not shown). Thus, the contribution of these events to malignant transformation of NIH3T3/mot-2.1 cells was excluded.
Malignant transformation occurred in all the mot-2.1, but not mot-2, NIH3T3 transfectants. These cDNAs dier only in the length of the 3'UTR region. This observation raised the possibility that the transforming activity may reside in the 3'UTR region of this gene analogous to the tumor suppressor activity detected in the 3'UTR region of the prohibitin and tropomyosin genes (Jupe et al., 1996; Rastinejad et al., 1993) . Therefore, we stably transfected only the 900-bp 3'UTR region of the mot-2.1 cDNA into NIH3T3 cells. None of the twenty isolated clones showed the transformed phenotype seen in mot-2.1 transfectants. Expression of the exogenous 3'UTR was detected in seven out of 20 isolated clones by RT ± PCR using a vector primer and a 3'UTR primer (data not shown). Hence, in our study, the 3'UTR per se could not account for malignant transformation of NIH3T3 cells. All 3'UTR-transfected clones had mot-2 protein levels equivalent to the control cells, but mot-2 and mot-2.1 transfectants showed signi®cantly higher levels, with the level of the protein in mot-2.1 transfectants being higher than that of mot-2 transfectants (Figure 1d) . A high level of mortalin expression in mot-2.1 as compared to mot-2 transfectants suggests a possible role of the 3'UTR region in translational eciency as has been suggested for a number of other genes (Jackson, 1993; Wilhelm and Vale, 1993; Wormington, 1994) . It has been proposed that the 3'UTR may (i) create a buer through which a putative 3'-5' exoribonuclease involved in mRNA turnover would need to progress before reaching the coding region and (ii) provide steric access by the ribosomes to the stop codon in the presence of a poly(A) + tail binding protein complex (Gallie et al., 1996; Munroe and Jacobson, 1990) . A poly(A) + sequence provided by the vector was present in both constructs, but mot-2.1 had ®ve additional putative polyadenylation signals in its 3'UTR. Taken together the data indicate that (i) mot- Figure 2 Western analysis of p53 and p81/Ezrin. Cells were grown in DMEM supplemented with 10% FBS and lyzed in Nonidet P-40 lysis buer (20 mM Tris (pH 7.5), 1 mM EDTA, 1 mM EGTA, 0.1 mM phenylmethylsulfonyl¯uoride, 150 mM NaCl, 1% Nonidet P-40) at 80% con¯uency. Protein extracts (50 mg for p53 and 10 mg for p81/Ezrin) were separated on sodium dodecyl sulfate-polyacrylamide gel, electroblotted onto a nitrocellulose membrane (BA85, Schleicher & Schuell) using a semidry transfer blotter (Biometra, Tokyo) and probed with antip53 antibody (PAb421) and p81/Ezrin antibody . The membranes were incubated with the appropriate secondary antibody coupled to horseradish peroxidase (hrp). The enhanced chemiluminescence detection system (Amersham) was utilized to visualize the antigen-antibody complexes. RS-4 cells were used as positive controls for detection of mutant p53 and high level of expression of p81/Ezrin .1 transfectants express higher levels of mot-2 protein than the mot-2 transfectants due to the presence of the 900 bp 3'UTR region in the former and (ii) it is the overexpression of mot-2 rather than the presence of the 3'UTR per se that is responsible for malignant transformation of the NIH3T3 cells. We also transfected NIH3T3 cells with expression plasmids containing mortalin cDNAs isolated from human transformed cells. Transfectants showed nonpancytosolic mortalin staining and morphological transformation. These were subsequently analysed for their ability to form tumors in nude mice. Twenty-one mice were injected with seven independent clones that were isolated following transfection of NIH3T3 cells with hmot-2A and hmot-2B, cDNAs isolated from HT1080 and HeLa cells that had 0.5 and 0.7 kb 3'UTR, respectively. As was seen with the NIH3T3/mot-2.1 transfectants, all seven clones formed tumors in nude mice (Table 3) . One vector transfected clone formed delayed and slowly progressing tumors in two mice while the other was as tumorigenic as the transfectants (Table 3) . The reason for transformation in one of the vector transfected controls may be due to the integration site of the plasmid or other independent events that remain unclear at present. This was further substantiated by injection of six mice with untransfected control cells. These mice showed delayed tumor formation, the average size of which was 1.761.7 cm at 30 days after injection as compared to the average size of 3.262.6 cm at 21 days in most of the transfectants. Taken together with the above results, it was concluded that overexpression of nonpancytosolic mortalin results in malignant transformation of NIH3T3 cells. To investigate the physiological relevance of these ®ndings we analysed mortalin expression level by Northern blotting in a variety of human transformed cells that were seen to exhibit a nonpancytosolic distribution of the protein. A high level of expression was apparent in bladder carcinoma, EJ; carcinogentransformed liver ®broblasts, SUSM-1; SV40-immortalized skin ®broblasts, GM847 (not shown) and GM2096/SV9; cervical carcinoma, HeLa; and osteogenic sarcoma, TE85 (not shown, as compared to normal bronchial ®broblasts, BF-10; and normal foreskin ®broblasts, HFF-5. Furthermore, SV40 immortalized post-crisis bronchial ®broblasts, BFT-3B (passage [p] 29) (De Silva and Reddel, 1993) , and epithelial cells, BET-3a (p26) and BET-3b (p29) (De Silva et al., 1994) were found to have a higher level of expression than their precrisis counterparts BFT-3B (p15) and BET-3a (p10) and BET-3b (p15), respectively. A similar increase in mortalin expression was also found in immortalized IIICF/c (p77) (Rogan et al., 1995) cells as compared to their pre-immortalized counterparts IIICF/c (p11) (Figure 3 ). An elevated level of nonpancytosolic mortalin expression has been observed in rat and human brain tumors (Kaul et al., Figure 3 Northern analysis of mortalin in normal and immortalized human cells at precrisis and postcrisis stages. Total RNA (10 mg) extracted from the cells indicated using ABI total RNA Isolation Reagent was separated on 1.5% denaturing agarose gel, transferred to Hybond N (Amersham) membrane by capillary transfer, and probed with the 32 P-radiolabeled 1.6 kb EcoRI 5' fragment of human mortalin cDNA (a). Intensity of ethidium bromide stained 28S RNA bands was taken as loading controls for quantitation, performed by using Micro Computer Imaging Device, MCID-M2 (FUJIX). The ratios of mortalin to ethidium bromide signals were plotted as relative units of mortalin expression (b) 1997; Takano et al., 1997) . Taken together with the present study, it is shown that mot-1 and mot-2, members of the hsp70 family of proteins, which dier from each other by only two amino acids, have contrasting biological activities. Whereas mot-1 is involved in cellular senescence (Wadhwa et al., 1993a,b) , mot-2, as shown in the present study, may have a role in in vitro and in vivo malignant transformation.
